Jan Östergren

About me
Publications
CV
Public outreach and news

About me

Jan Östergren is Professor Emeritus of Medicine. His research is primarily about angiology, i.e. vascular medicine and hypertension/high blood pressure.

Articles

Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. HYPERTENSION. 2021;8:100074

Ambulatory blood pressure monitoring and blood pressure control in patients with coronary artery disease-A randomized controlled trial.

Hägglund O; Svensson P; Linde C; Östergren J
Article: JOURNAL OF HYPERTENSION. 2021;39(2):243-249

Changes in 24-h ambulatory blood pressure following restoration of sinus rhythm in patients with atrial fibrillation.

Olbers J; Östergren J; Rosenqvist M; Skuladottir H; Klavebäck S; Ljungman P; Witt N
Article: ANNALS OF EMERGENCY MEDICINE. 2019;74(3):345-356

Associations Between Crowding and Ten-Day Mortality Among Patients Allocated Lower Triage Acuity Levels Without Need of Acute Hospital Care on Departure From the Emergency Department.

Berg LM; Ehrenberg A; Florin J; Östergren J; Discacciati A; Göransson KE
Article: JMIR MEDICAL EDUCATION. 2019;5(2):e12791

Why Medical Students Choose to Use or Not to Use a Web-Based Electrocardiogram Learning Resource: Mixed Methods Study.

Nilsson M; Fors U; Östergren J; Bolinder G; Edelbring S
Article: INTERNATIONAL EMERGENCY NURSING. 2019;43:50-55

Significant changes in emergency department length of stay and case mix over eight years at a large Swedish University Hospital.

Berg LM; Ehrenberg A; Florin J; Östergren J; Göransson KE
Article: JOURNAL OF CLINICAL HYPERTENSION. 2019;21(3):363-368

Systolic blood pressure increases in patients with atrial fibrillation regaining sinus rhythm after electrical cardioversion.

Olbers J; Jacobson E; Viberg F; Witt N; Ljungman P; Rosenqvist M; Östergren J
Article: BLOOD PRESSURE. 2018;27(5):249-255

High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm.

Olbers J; Gille A; Ljungman P; Rosenqvist M; Östergren J; Witt N
Article: INTERNATIONAL EMERGENCY NURSING. 2017;33:14-19

Physicians' and nurses' perceptions of patient safety risks in the emergency department.

Källberg A-S; Ehrenberg A; Florin J; Östergren J; Göransson KE
Article: NEONATOLOGY. 2017;112(1):87-91

Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm.

Kistner A; Jacobson L; Östergren J; Hellström A
Article: INTERNATIONAL EMERGENCY NURSING. 2016;29:21-26

Reasons for interrupting colleagues during emergency department work - A qualitative study.

Berg LM; Florin J; Ehrenberg A; Östergren J; Djärv T; Göransson KE
Article: BLOOD PRESSURE. 2016;25(5):286-291

Improvement of blood pressure control and physicians' management over time in patients with coronary artery disease.

Hägglund O; Sjöqvist I; Linde C; Svensson P; Östergren J
Article: INTERNATIONAL EMERGENCY NURSING. 2016;27:11-16

Factors influencing clinicians' perceptions of interruptions as disturbing or non-disturbing: A qualitative study.

Berg LM; Källberg A-S; Ehrenberg A; Florin J; Östergren J; Djärv T; Brixey JJ; Göransson KE
Article: INTERNATIONAL EMERGENCY NURSING. 2015;23(2):156-161

Contributing factors to errors in Swedish emergency departments.

Källberg A-S; Göransson KE; Florin J; Östergren J; Brixey JJ; Ehrenberg A
Article: JOURNAL OF CLINICAL HYPERTENSION. 2015;17(2):141-146

Amlodipine+benazepril is superior to hydrochlorothiazide+benazepril irrespective of baseline pulse pressure: subanalysis of the ACCOMPLISH trial.

Skoglund PH; Svensson P; Asp J; Dahlöf B; Kjeldsen SE; Jamerson KA; Weber MA; Jia Y; Zappe DH; Östergren J; ACCOMPLISH investigators
Article: DIABETES & VASCULAR DISEASE RESEARCH. 2014;11(3):133-173

ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.

Task Force on diabetes, pre-diabetes, and cardiova; European Association for the Study of Diabetes (EA; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
Article: AMERICAN JOURNAL OF HYPERTENSION. 2014;27(3):363-371

Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.

Skoglund PH; Arpegård J; Ostergren J; Svensson P
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2014;16(1):33-40

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved.

Rogers JK; Pocock SJ; McMurray JJV; Granger CB; Michelson EL; Östergren J; Pfeffer MA; Solomon SD; Swedberg K; Yusuf S
Article: EUROPEAN HEART JOURNAL. 2013;34(39):3035-3087

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).

Authors/Task Force Members; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Zamorano JL; ESC Committee for Practice Guidelines (CPG); Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; Document Reviewers; De Backer G; Sirnes PA; Ezquerra EA; Avogaro A; Badimon L; Baranova E; Baumgartner H; Betteridge J; Ceriello A; Fagard R; Funck-Brentano C; Gulba DC; Hasdai D; Hoes AW; Kjekshus JK; Knuuti J; Kolh P; Lev E; Mueller C; Neyses L; Nilsson PM; Perk J; Ponikowski P; Reiner Z; Sattar N; Schächinger V; Scheen A; Schirmer H; Strömberg A; Sudzhaeva S; Tamargo JL; Viigimaa M; Vlachopoulos C; Xuereb RG
Article: BMJ QUALITY & SAFETY. 2013;22(8):656-663

Interruptions in emergency department work: an observational and interview study.

Berg LM; Källberg A-S; Göransson KE; Östergren J; Florin J; Ehrenberg A
Article: JOURNAL OF HYPERTENSION. 2013;31(7):1281-1357

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G; Fagard R; Narkiewicz K; Redón J; Zanchetti A; Böhm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Task Force Members
Article: EUROPEAN JOURNAL OF EMERGENCY MEDICINE. 2013;20(1):33-38

Medical errors and complaints in emergency department care in Sweden as reported by care providers, healthcare staff, and patients - a national review.

Källberg A-S; Göransson KE; Östergren J; Florin J; Ehrenberg A
Article: KARDIOLOGIA POLSKA. 2013;71 Suppl 11:S319-S394

[ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].

Grupa Robocza Europejskiego Towarzystwa Kardiologi; Rydén L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Sousa Uva M; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Zamorano JL; European Association for the Study of Diabetes (EA
Article: BLOOD PRESSURE. 2012;21(4):227-232

Ambulatory pulse pressure predicts cardiovascular events in patients with peripheral arterial disease.

Skoglund PH; Östergren J; Svensson P
Article: EUROPEAN JOURNAL OF EMERGENCY MEDICINE. 2012;19(4):246-251

An observational study of activities and multitasking performed by clinicians in two Swedish emergency departments.

Berg LM; Ehrenberg A; Florin J; Ostergren J; Göransson KE
Article: ANNALS OF MEDICINE. 2012;44(3):262-270

Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease.

Holzmann MJ; Jungner I; Walldius G; Ivert T; Nordqvist T; Ostergren J; Hammar N
Article: BLOOD PRESSURE. 2012;21(2):82-87

Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.

Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlöf B; Velazquez EJ; Hua TA; Kelly RY; Zappe D; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M; Avoiding Cardiovascular Events Through Combination
Article: BMC MEDICAL EDUCATION. 2012;12:5

Does individual learning styles influence the choice to use a web-based ECG learning programme in a blended learning setting?

Nilsson M; Östergren J; Fors U; Rickenlund A; Jorfeldt L; Caidahl K; Bolinder G
Article: AMERICAN HEART JOURNAL. 2011;162(5):900-906

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program.

Ariti CA; Cleland JGF; Pocock SJ; Pfeffer MA; Swedberg K; Granger CB; McMurray JJV; Michelson EL; Ostergren J; Yusuf S
Article: INTERNATIONAL ANGIOLOGY. 2011;30(2):150-155

The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia.

Belch JJF; Ray S; Rajput-Ray M; Engeset J; Fagrell B; Lepäntalo M; McKay A; Mackay IR; Ostergren J; Ruckley CV; Salenius J
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2010;44(6):325-330

Change in blood pressure during hospitalisation for acute heart failure predicts mortality.

Svensson P; Sundberg H; Lund LH; Östergren J
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2010;12(6):557-565

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme.

Hawkins NM; Wang D; Petrie MC; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Solomon SD; Ostergren J; Michelson EL; Pocock SJ; Maggioni AP; McMurray JJV; CHARM Investigators and Committees
Article: JOURNAL OF INTERNAL MEDICINE. 2010;267(4):357-369

Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle-aged men and women.

Holzmann MJ; Ivert T; Jungner I; Nordqvist T; Walldius G; Ostergren J; Hammar N
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2009;11(11):1092-1098

Adherence to medication according to sex and age in the CHARM programme.

Granger BB; Ekman I; Granger CB; Ostergren J; Olofsson B; Michelson E; McMurray JJV; Yusuf S; Pfeffer MA; Swedberg K
Article: JOURNAL OF INTERNAL MEDICINE. 2009;266(5):457-466

Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.

Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P; CASTOR investigators
Article: LAKARTIDNINGEN. 2009;106(38):2354-2356

[Variation of internship test results depends on the seat of learning and age. Analysis of tests 1995-2008].

Ostergren J; Kaviani C; Thorvaldsen T; Krook-Brandt M; Dahlgren L-O
Article: DIABETES CARE. 2009;32(5):915-920

Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Preiss D; Zetterstrand S; McMurray JJV; Ostergren J; Michelson EL; Granger CB; Yusuf S; Swedberg K; Pfeffer MA; Gerstein HC; Sattar N; Candesartan in Heart Failure Assessment of Reducti
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2008;52(24):2000-2007

Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.

Meredith PA; Ostergren J; Anand I; Puu M; Solomon SD; Michelson EL; Olofsson B; Granger CB; Yusuf S; Swedberg K; Pfeffer MA; McMurray JJV
Article: JOURNAL OF HYPERTENSION. 2008;26(11):2103-2111

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.

Ostergren J; Poulter NR; Sever PS; Dahlöf B; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; ASCOT investigators
Article: EUROPEAN HEART JOURNAL. 2008;29(21):2641-2650

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.

Pocock SJ; McMurray JJV; Dobson J; Yusuf S; Granger CB; Michelson EL; Ostergren J; Pfeffer MA; Solomon SD; Anker SD; Swedberg KB
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2008;102(6):733-737

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Article: ATHEROSCLEROSIS. 2008;199(2):397-401

Cystatin C--a marker of peripheral atherosclerotic disease?

Arpegård J; Ostergren J; de Faire U; Hansson L-O; Svensson P
Article: EUROPEAN HEART JOURNAL. 2008;29(11):1377-1385

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

MacDonald MR; Petrie MC; Varyani F; Ostergren J; Michelson EL; Young JB; Solomon SD; Granger CB; Swedberg K; Yusuf S; Pfeffer MA; McMurray JJV; CHARM Investigators
Article: BMC MEDICAL EDUCATION. 2008;8:25

Evaluation of a web-based ECG-interpretation programme for undergraduate medical students.

Nilsson M; Bolinder G; Held C; Johansson B-L; Fors U; Ostergren J
Article: EUROPEAN HEART JOURNAL. 2008;29(4):499-508

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.

Sever PS; Poulter NR; Dahlof B; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes G; Mehlsen J; Nieminen MS; O'Brien ET; Ostergren J; ASCOT Investigators
Article: BLOOD PRESSURE. 2008;17(1):7-17

Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.

Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlöf B; Velazquez EJ; Gupte J; Staikos L; Hua TA; Shi V; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M; Avoiding Cardiovascular events through COMbination
Article: CIRCULATION. 2007;115(24):3111-3120

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

O'Meara E; Clayton T; McEntegart MB; McMurray JJV; Piña IL; Granger CB; Ostergren J; Michelson EL; Solomon SD; Pocock S; Yusuf S; Swedberg K; Pfeffer MA; CHARM Investigators
Journal article: JOURNAL OF HYPERTENSION. 2007;25(6):1462-1536

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G; De Backer G; Dominiczak A; Cifkova R; Fagard R; Germano G; Grassi G; Heagerty AM; Kjeldsen SE; Laurent S; Narkiewicz K; Ruilope L; Rynkiewicz A; Schmieder RE; Boudier HAJS; Zanchetti A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Filippatos G; Funck-Brentano C; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Erdine S; Kiowski W; Agabiti-Rosei E; Ambrosioni E; Lindholm LH; Viigimaa M; Adamopoulos S; Agabiti-Rosei E; Ambrosioni E; Bertomeu V; Clement D; Erdine S; Farsang C; Gaita D; Lip G; Mallion J-M; Manolis AJ; Nilsson PM; O'Brien E; Ponikowski P; Redon J; Ruschitzka F; Tamargo J; van Zwieten P; Waeber B; Williams B; Management of Arterial Hypertension of the Europea; European Society of Cardiology
Journal article: EUROPEAN HEART JOURNAL. 2007;28(12):1105-1187

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G; De Backer G; Dominiczak A; Cifkova R; Fagard R; Germano G; Grassi G; Heagerty AM; Kjeldsen SE; Laurent S; Narkiewicz K; Ruilope L; Rynkiewicz A; Schmieder RE; Struijker Boudier HAJ; Zanchetti A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Filippatos G; Funck-Brentano C; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Kjeldsen SE; Erdine S; Narkiewicz K; Kiowski W; Agabiti-Rosei E; Ambrosioni E; Cifkova R; Dominiczak A; Fagard R; Heagerty AM; Laurent S; Lindholm LH; Mancia G; Manolis A; Nilsson PM; Redon J; Schmieder RE; Struijker-Boudier HAJ; Viigimaa M; Filippatos G; Adamopoulos S; Agabiti-Rosei E; Ambrosioni E; Bertomeu V; Clement D; Erdine S; Farsang C; Gaita D; Kiowski W; Lip G; Mallion J-M; Manolis AJ; Nilsson PM; O'Brien E; Ponikowski P; Redon J; Ruschitzka F; Tamargo J; van Zwieten P; Viigimaa M; Waeber B; Williams B; Zamorano JL; The task force for the management of arterial hype; The task force for the management of arterial hype
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2007;9(5):510-517

Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.

Hawkins NM; Wang D; McMurray JJV; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG; CHARM Investigators and Committees
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007;49(6):687-694

Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.

Persson H; Lonn E; Edner M; Baruch L; Lang CC; Morton JJ; Ostergren J; McKelvie RS; Investigators of the CHARM Echocardiographic Subst
Article: HEART. 2007;93(1):59-64

Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.

Hawkins NM; Wang D; McMurray JJV; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG; CHARM Investigators and Committees
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2007;27(1):30-35

Myocardial ischaemia in patients with peripheral arterial disease.

Svensson P; de Faire U; Niklasson U; Ostergren J
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2006;7 Suppl 1:S1-S7

Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.

Nickenig G; Ostergren J; Struijker-Boudier H
Article: EUROPEAN HEART JOURNAL. 2006;27(12):1447-1458

Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

McMurray JJV; Andersson FL; Stewart S; Svensson K; Solal AC; Dietz R; Vanhaecke J; van Veldhuisen DJ; Ostergren J; Granger CB; Yusuf S; Pfeffer MA; Swedberg K
Article: AMERICAN HEART JOURNAL. 2006;151(5):985-991

Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.

McMurray JJV; Young JB; Dunlap ME; Granger CB; Hainer J; Michelson EL; Earle S; Olofsson B; Ostergren J; Yusuf S; Swedberg K; Pfeffer MA; CHARM Investigators
Article: CIRCULATION. 2006;113(7):986-994

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.

O'Meara E; Clayton T; McEntegart MB; McMurray JJV; Lang CC; Roger SD; Young JB; Solomon SD; Granger CB; Ostergren J; Olofsson B; Michelson EL; Pocock S; Yusuf S; Swedberg K; Pfeffer MA; CHARM Committees and Investigators
Article: CIRCULATION. 2006;113(5):671-678

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Hillege HL; Nitsch D; Pfeffer MA; Swedberg K; McMurray JJV; Yusuf S; Granger CB; Michelson EL; Ostergren J; Cornel JH; de Zeeuw D; Pocock S; van Veldhuisen DJ; Candesartan in Heart Failure: Assessment of Reduct
Article: EUROPEAN HEART JOURNAL. 2006;27(1):65-75

Predictors of mortality and morbidity in patients with chronic heart failure.

Pocock SJ; Wang D; Pfeffer MA; Yusuf S; McMurray JJV; Swedberg KB; Ostergren J; Michelson EL; Pieper KS; Granger CB
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2005;294(14):1794-1798

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.

Demers C; McMurray JJV; Swedberg K; Pfeffer MA; Granger CB; Olofsson B; McKelvie RS; Ostergren J; Michelson EL; Johansson PA; Wang D; Yusuf S; CHARM Investigators
Article: LANCET. 2005;366(9489):907-913

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

Poulter NR; Wedel H; Dahlöf B; Sever PS; Beevers DG; Caulfield M; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J; Pocock S; ASCOT Investigators
Article: LANCET. 2005;366(9489):895-906

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J; ASCOT Investigators
Article: CIRCULATION. 2005;112(1):48-53

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure.

Yusuf S; Ostergren JB; Gerstein HC; Pfeffer MA; Swedberg K; Granger CB; Olofsson B; Probstfield J; McMurray JV; Candesartan in Heart Failure-Assessment of Reducti
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2005;7(4):650-656

Patient perception of the effect of treatment with candesartan in heart failure. Results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.

O'Meara E; Lewis E; Granger C; Dunlap ME; McKelvie RS; Probstfield JL; Young JB; Michelson EL; Ostergren J; Carlsson J; Olofsson B; McMurray J; Yusuf S; Swedberg K; Pfeffer MA
Article: DIABETES CARE. 2005;28(5):1151-1157

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Sever PS; Poulter NR; Dahlöf B; Wedel H; Collins R; Beevers G; Caulfield M; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J
Article: JOURNAL OF CARDIOVASCULAR RISK. 2005;12(1):75-81

Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.

Dagenais GR; Yi Q; Lonn E; Sleight P; Ostergren J; Yusuf S; HOPE Trial Investigators
Article: BLOOD PRESSURE. 2005;14(2):99-106

Plasma NT-proBNP concentration is related to ambulatory pulse pressure in peripheral arterial disease.

Svensson P; de Faire U; Niklasson U; Hansson L-O; Ostergren J
Article: CIRCULATION. 2004;110(17):2618-2626

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.

Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJV; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K; Candesartan in Heart failure Assessment of Reducti
Article: JOURNAL OF HUMAN HYPERTENSION. 2004;18(3):193-200

Office blood pressure underestimates ambulatory blood pressure in peripheral arterial disease in comparison to healthy controls.

Svensson P; de Faire U; Niklasson U; Ostergren J
Article: EUROPEAN HEART JOURNAL. 2004;25(1):17-24

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.

Ostergren J; Sleight P; Dagenais G; Danisa K; Bosch J; Qilong Y; Yusuf S; HOPE study investigators
Article: LANCET. 2003;362(9386):777-781

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Yusuf S; Pfeffer MA; Swedberg K; Granger CB; Held P; McMurray JJV; Michelson EL; Olofsson B; Ostergren J; CHARM Investigators and Committees
Article: LANCET. 2003;362(9386):772-776

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

Granger CB; McMurray JJV; Yusuf S; Held P; Michelson EL; Olofsson B; Ostergren J; Pfeffer MA; Swedberg K; CHARM Investigators and Committees
Article: LANCET. 2003;362(9386):767-771

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

McMurray JJV; Ostergren J; Swedberg K; Granger CB; Held P; Michelson EL; Olofsson B; Yusuf S; Pfeffer MA; CHARM Investigators and Committees
Article: LANCET. 2003;362(9386):759-766

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Pfeffer MA; Swedberg K; Granger CB; Held P; McMurray JJV; Michelson EL; Olofsson B; Ostergren J; Yusuf S; Pocock S; CHARM Investigators and Committees
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2003;4(3):171-175

Angiotensin receptor blockers in heart failure.

Stergren J; McMurray JJV
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2003;5(3):261-270

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme.

McMurray J; Ostergren J; Pfeffer M; Swedberg K; Granger C; Yusuf S; Held P; Michelson E; Olofsson B; CHARM committees and investigators
Article: LANCET. 2003;361(9364):1149-1158

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J; ASCOT investigators
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2002;22(6):370-374

Skin microvascular dilatation response to acetylcholine and sodium nitroprusside in peripheral arterial disease.

Jägrén C; Gazelius B; Ihrman-Sandal C; Lindblad L-E; Ostergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2002;251(6):508-517

The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub-study to the HOPE study.

Björholt I; Andersson FL; Kahan T; Ostergren J
Article: BMJ-BRITISH MEDICAL JOURNAL. 2002;324(7339):699-702

Use of ramipril in preventing stroke: double blind randomised trial.

Bosch J; Yusuf S; Pogue J; Sleight P; Lonn E; Rangoonwala B; Davies R; Ostergren J; Probstfield J; HOPE Investigators. Heart outcomes prevention eval
Article: HYPERTENSION. 2001;38(6):E28-E32

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

Svensson P; de Faire U; Sleight P; Yusuf S; Ostergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2001;250(5):398-405

Episodes of ST-segment depression is related to changes in ambulatory blood pressure and heart rate in intermittent claudication.

Svensson P; Niklasson U; Ostergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2001;250(5):390-397

Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics.

Frykman V; Frick M; Jensen-Urstad M; Ostergren J; Rosenqvist M
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2001;55(7):449-457

What is the relevance of the HOPE study in general practice?

Kennedy J; Mogensen CE; Ball SG; Castaigne AD; Commerford PJ; Distiller L; Fisher BM; Gonzalez-Jaunatey J; Nosadini R; Novials A; Ostergren J; Palma-Gámiz J; Perrone-Filardi P; Schipperheijn JJ; Senges J; Trevisan R
Article: JOURNAL OF HUMAN HYPERTENSION. 2001;15 Suppl 1:S11-S12

Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.

Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J; ASCOT Steering Committee, Anglo-Scandinavian Cardi
Article: JOURNAL OF HYPERTENSION. 2001;19(6):1167-1176

Regression of left ventricular hypertrophy in human hypertension with irbesartan.

Malmqvist K; Kahan T; Edner M; Held C; Hägg A; Lind L; Müller-Brunotte R; Nyström F; Ohman KP; Osbakken MD; Ostergern J
Article: JOURNAL OF HYPERTENSION. 2001;19(6):1139-1147

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators.

Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J
Article: CLINICAL CARDIOLOGY. 2001;24(3):238-244

Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation.

Frick M; Frykman V; Jensen-Urstad M; Ostergren J; Rosenqvist M
Article: JOURNAL OF HYPERTENSION. 2001;19(2):311-317

Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension.

Malmqvist K; Isaksson H; Ostergren J; Kahan T
Article: BLOOD PRESSURE. 2001;10(2):101-110

Regression of left ventricular mass with captopril and metoprolol, and the effects on glucose and lipid metabolism.

Malmqvist K; Kahan T; Isaksson H; Ostergren J
Article: EUROPEAN HEART JOURNAL. 2000;21(14):1177-1185

The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.

Frick M; Darpö B; Ostergren J; Rosenqvist M
Article: BLOOD PRESSURE. 2000;9(6):340-345

Less difference between office and ambulatory blood pressure in women than in men both before and during antihypertensive treatment.

Nyström FH; Ohman KP; Isaksson H; Schwan A; Ostergren J
Article: LAKARTIDNINGEN. 1999;96(48):5326-5327

[Is it time to reconsider the guidelines for hypertension therapy? Several new international recommendations published].

Ostergren J
Article: JOURNAL OF CARDIAC FAILURE. 1999;5(3):276-282

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.

Swedberg K; Pfeffer M; Granger C; Held P; McMurray J; Ohlin G; Olofsson B; Ostergren J; Yusuf S
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1999;84(1):104-A9

Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation.

Frick M; Ostergren J; Rosenqvist M
Article: DIABETES CARE. 1999;22(1):147-151

Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers.

Kalani M; Brismar K; Fagrell B; Ostergren J; Jörneskog G
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1998;32(5):753-759

Adrenaline responsiveness in mild hypertension: no evidence for altered beta-adrenoceptor sensitivity.

Kahan T; Hjemdahl P; Lindvall K; Ostergren J; de Faire U
Article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 1998;2(3):82

Urokinase reduced the need for open surgical procedures in acute ischemia of the leg.

Ostergren J
Article: LAKARTIDNINGEN. 1998;95(32-33):3380-3381

[New discoveries on target blood pressure and ACE inhibitors. Swedish guidelines on hypertension are still correct].

Ostergren J
Article: AMERICAN JOURNAL OF HYPERTENSION. 1998;11(6 Pt 1):690-696

Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension.

Ostergren J; Isaksson H; Brodin U; Schwan A; Ohman KP
Article: JOURNAL OF HYPERTENSION. 1997;15(11):1327-1335

Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being. LOA Study Group.

Dahlöf B; Lindholm LH; Carney S; Pentikäinen PJ; Ostergren J
Article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 1997;1(2):38

Ankle brachial index is a predictor of 5-year cardiovascular events.

Ostergren J
Article: BLOOD PRESSURE. 1996;5(1):41-49

Quality of life in hypertensive patients treated with either carvedilol or enalapril.

Ostergren J; Storstein L; Karlberg BE; Tibblin G
Show more

All other publications

Review: EUROPEAN HEART JOURNAL. 2013;34(28):2159-2219

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G; Fagard R; Narkiewicz K; Redon J; Zanchetti A; Böhm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Redon J; Dominiczak A; Narkiewicz K; Nilsson PM; Burnier M; Viigimaa M; Ambrosioni E; Caufield M; Coca A; Olsen MH; Schmieder RE; Tsioufis C; van de Borne P; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; Clement DL; Coca A; Gillebert TC; Tendera M; Rosei EA; Ambrosioni E; Anker SD; Bauersachs J; Hitij JB; Caulfield M; De Buyzere M; De Geest S; Derumeaux GA; Erdine S; Farsang C; Funck-Brentano C; Gerc V; Germano G; Gielen S; Haller H; Hoes AW; Jordan J; Kahan T; Komajda M; Lovic D; Mahrholdt H; Olsen MH; Ostergren J; Parati G; Perk J; Polonia J; Popescu BA; Reiner Z; Rydén L; Sirenko Y; Stanton A; Struijker-Boudier H; Tsioufis C; van de Borne P; Vlachopoulos C; Volpe M; Wood DA
Review: LAKARTIDNINGEN. 2012;109(36):1544-1548

[Hypertension is a clinical problem ... even though we have tools to solve it].

Ostergren J
Letter: THROMBOSIS RESEARCH. 2010;125(5):473-474

Poor performance with a platelet counting technique to monitor clopidogrel inhibitory effects in the point-of-care setting.

Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P; CASTOR investigators
Review: JOURNAL OF CLINICAL HYPERTENSION. 2009;11(2):66-73

Where are we with the management of hypertension? From science to clinical practice.

Farsang C; Naditch-Brule L; Avogaro A; Ostergren J; Verdecchia P; Maggioni A; van de Borne P; Lins R; Roca-Cusachs A
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2008;9(1):205

LIPID LOWERING EFFICACY OF ROSUVASTATIN VS ATORVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE

Ostergren J; Malmstrom R; Jorgensen L; Walldius G
Review: EUROPEAN HEART JOURNAL SUPPLEMENTS. 2007;9(C):C3-C74

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases:: full text

Ryden L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer M-J; Cosentino F; Jonsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Qiao Q; Priori SG; Blanc J-J; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Luis Zamorano J; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; GohIke H; Gonzalez Juanatey JR; Graham I; Monteiro PF; Parhofer K; Pyorala K; Raz I; Schernthaner G; Volpe M; Wood D
Published paper: DIABETES RESEARCH AND CLINICAL PRACTICE. 2007;76 Suppl 1:S13-S21

Renin-angiotensin-system blockade in the prevention of diabetes.

Ostergren J
Editorial comment: DIABETES RESEARCH AND CLINICAL PRACTICE. 2007;76:S1-S2

Angiotensin receptor blockers in the prevention and management of diabetes and its complications -: Introduction

Ostergren J
Review: EUROPEAN HEART JOURNAL. 2007;28(1):88-136

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

Rydén L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer M-J; Cosentino F; Jönsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Qiao Q; Priori SG; Blanc J-J; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Zamorano JL; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; Gohlke H; Juanatey JRG; Graham I; Monteiro PF; Parhofer K; Pyörälä K; Raz I; Schernthaner G; Volpe M; Wood D; Task Force on Diabetes and Cardiovascular Diseases; European Association for the Study of Diabetes (EA
Review: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2006;7(2):64-73

From hypertension to heart failure -- are there better primary prevention strategies?

Meredith PA; Ostergren J
Published paper: JOURNAL OF HYPERTENSION, SUPPLEMENT. 2006;24(1):S3-S7

Angiotensin receptor blockade with candesartan in heart failure: findings from the Candesartan in Heart failure--assessment of reduction in mortality and morbidity (CHARM) programme.

Ostergren JB
Meeting abstract: JOURNAL OF CARDIAC FAILURE. 2004;10(4):S76

Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: Results of the CHARM low

Young JB; Swedberg K; Dunlap ME; Pfeffer MA; Probstfield JL; Granger CB; McKelvey RS; McMurray MJV; Michaelson EL; Olofsson B; Ostergren J; Yusuf S
Review: EXPERT OPINION ON PHARMACOTHERAPY. 2004;5(7):1589-1597

Candesartan for the treatment of hypertension and heart failure.

Ostergren J
Meeting abstract: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2004;43(5):A473

Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure

Yusuf S; Ostergren JB; Gerstein H; Pfeffer MA; Swedberg K; Granger CB; McMurray JJV
Published paper: DRUGS. 2004;64 Suppl 2:43-60

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J; ASCOT Investigators
Letter: HYPERTENSION. 2003;41(4):E5

Response:: HOPE not HYPE but mechanisms can be discussed

Svensson P; Östergren J
Editorial comment: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2002;24(1):4-5

Is there a need for the medical angiologist?

Ostergren J; Fagrell B
Published paper: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2001;(117):19-21

Pharmacoeconomic impact of HOPE.

Ostergren JB; Björholt I; Andersson F; Kahan T
Review: LAKARTIDNINGEN. 1999;96(13):1585-1590

[Intermittent claudication--a major cardiovascular risk factor. Proposed guidelines for investigation and treatment].

Svensson P; Wahlberg E; Hedin U; Ostergren J
Editorial comment: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 1998;:2

The role of ACE inhibitors in the prevention and treatment of atherosclerosis: a clinical approach - Introduction

Ostergren J

Employments

Project Manager, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, 2024-2024
Affiliated to Research, Department of Medicine, Karolinska Institutet, 2021-2024

Degrees and Education

Docent, Karolinska Institutet, 1988

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI